Garen Bohlin - Sep 12, 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Garen Bohlin
Stock symbol
KPTI
Transactions as of
Sep 12, 2023
Transactions value $
$49,985
Form type
4
Date filed
9/12/2023, 04:07 PM
Previous filing
May 25, 2023
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Purchase $50K +41.1K +1028.5% $1.22 45.1K Sep 12, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price..